Background And Objectives: Antibodies to proteolipid protein-1 (PLP1-IgG), a major central myelin protein also expressed in the peripheral nervous system (PNS) as the isoform DM20, have been previously identified mostly in patients with multiple sclerosis (MS), with unclear clinical implications. However, most studies relied on nonconformational immunoassays and included few patients with non-MS CNS autoimmune demyelinating disorders (ADDs). We aimed to investigate conformational PLP1-IgG in the whole ADD spectrum.
View Article and Find Full Text PDF: Paraneoplastic neurological syndromes (PNSs) are rare conditions characterized by immune-mediated pathogenesis, frequently associated with the presence of a neoplasm. Although a single antineuronal antibody mediates a specific syndrome, atypical manifestations mediated by the same antibody have been described. : The aim of this study was to report on an atypical case of PNS with dual positivity for anti-GAD65 and anti-CRMP5/CV2 antibodies, simultaneously characterized by cognitive decline associated with progressive ataxia and parkinsonism.
View Article and Find Full Text PDFThe thermodynamically unstable interface between metallic lithium and electrolyte poses a major problem for the massive commercialization of Li-metal batteries. In this study, we propose the use of a multicomponent protective coating based on cellulose modified with dimethylthexylsilyl group (TDMSC), single-ion conducting polymer P(LiMTFSI), and LiNO (TDMSC-P(LiMTFSI)-LiNO, namely PTL). The coating shows its positive effect by increasing the Coulombic efficiency in Li || Cu cells from 95.
View Article and Find Full Text PDFThe management of end-of-life vehicles (ELVs) has become a significant environmental and economic challenge due to the substantial volumes of hazardous waste generated. This article analyses sustainable practices in ELV management across Europe, with a focus on contributions to the circular economy. The systematic literature review, conducted for articles published in the period 2016-2024, identifies five topics: (1) policy and regulatory frameworks evaluations and suggestions; (2) economic and environmental benefits through optimization modelling; (3) trends and performances analysis; (4) advanced treatment technologies and their impact and (5) economic and environmental impacts assessments.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
November 2024